This is especially beneficial for those facing obesity, as it helps manage cravings and promotes healthier eating habits
Civil Engineering, UCLA Last updated: July 2026 Human-researched and AI-assisted with full editorial review
If we can identify and target those pathways directly, future therapies could be even more effective. Not everyone responds the same way Despite their effectiveness, GLP-1 drugs do not work equally well for everyone
GLP-1 receptor agonists, the drug class that includes semaglutide (sold as Ozempic and Wegovy), appear to reduce cravings, lower overdose risk and decrease substance use disorder diagnoses in
Contrave led to a 4.1% greater weight loss than placebo in six randomized controlled trials with 9,949 participants
Patients considering combination approaches should understand that this represents an unproven strategy that increases cost and injection burden without documented benefit